Lessons from University Presses — Economics, Spin, Misfits, and Mission
The University of Missouri saga has many lessons for publishers of all types. But perhaps the harshest lesson is that we’re in a tough business.
The University of Missouri saga has many lessons for publishers of all types. But perhaps the harshest lesson is that we’re in a tough business.
The EU follows in lockstep with the UK, with a statement instead of a mandate. Are the gloves about to come off?
A lurid story of intramural hijinks at the FDA shows how far from mission an organization can drift when it gets its priorities wrong.
The RCUK announces its OA plans, including a six-month embargo. Now, speculation snaps into reality, and we will see if a number of lurking unintended consequences come to pass.
Society publishing is surrounded by rivalrous groups, which tend to undermine the societies’ activities. It’s time to renew the development of membership through exclusive products.
In order for publishers to engage in direct marketing, they have to build new infrastructure. Simon & Schuster is hinting at new developments with its use of QR codes.
A fluidic computer designed to model a national economy holds lessons for doing things directly and physically. Sometimes, you have to get your hands wet.
Creative people are using our inputs — and letting us do the same — to drive more creativity.
Siri now has competition, and we all benefit.
Amateurs hope they can emulate the professionals they admire. In a set of videos of F1 racing courses, it’s clear that amateurs can’t compete with professional drivers.
A short video demonstrating how a friction idiophone works magic!
A fascinating set of new video techniques being developed at MIT hint at how cameras might someday intervene in crib death, help diagnose heart disease, and more.
Hi-speed cameras capture something you’ve probably done, but never really seen — the levitating Slinky.
Tracking pizza deliveries tells us a lot about one of our major cities, its inhabitants, socioeconomic aspects, and more.
Consent and confidentiality concerns around “Big Data” in medicine should give enthusiasts for a data-rich scientific world pause. Things are more complex, and the answers so far are inadequate.